What Has Been the Progress and Growth of the Pulmonology Devices Market in Recent Years?
The pulmonology devices market has seen considerable growth due to a variety of factors.
• The pulmonology devices market has experienced significant growth in recent years. It will rise from $1.36 billion in 2024 to $1.51 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%.
This growth is due to the increasing prevalence of chronic respiratory diseases, a shift towards preventive healthcare, higher adoption of pulmonology devices, a rise in procedures requiring endoscopic ultrasound, and an aging population.
What Can Be Expected from the Pulmonology Devices Market Size?
The pulmonology devices market is expected to maintain its strong growth trajectory in upcoming years.
• The pulmonology devices market is forecasted to grow to $2.26 billion by 2029 at a CAGR of 10.7%.
Growth is driven by the rise of respiratory diseases, air pollution, home healthcare, and healthcare infrastructure expansion. Trends include AI integration, telemedicine, portable device advancements, and robotic diagnostic technologies.
What Are the Critical Driver Fuelling The Pulmonology Devices Market's Growth?
The increasing number of individuals suffering from respiratory diseases is anticipated to boost the development of the pulmonology devices market. Respiratory diseases pertain to issues affecting the breathing organs and tissues, including the airways, lungs, and respiratory muscles. These ailments are becoming more common due to factors such as elevated air pollution, smoking, and workplace risks. Pulmonology devices contribute significantly to managing respiratory diseases, providing precise diagnoses, constant monitoring, and efficient treatments with tools like spirometers, inhalers, pulse oximeters, and ventilators, ultimately enhancing patient results and quality of life. For example, as per the Australian Institute of Health and Welfare's data in June 2024, an estimated 8.5 million, or 34% of Australians were living with chronic respiratory illnesses. This includes around 2.8 million people, or 11% of the country's population, diagnosed with asthma, and 638,000 people, or 2.5% of the population, battling chronic obstructive pulmonary disease (COPD). Consequently, the increasing incidence of respiratory diseases is contributing to the growth of the pulmonology devices market.
How Is The Pulmonology Devices Market segmented?
The pulmonology devices market covered in this report is segmented –
1) By Product Type: Endobronchial Ultrasound (EBUS) Needles, Pulmonary Biopsy Devices, Airway Stents, Single-Use Bronchoscopes, Other Product Types
2) By Indication: Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, Tracheal And Bronchial Stenosis, Foreign Body Extraction, Other Indications
3) By End-User: Pulmonology Clinics, Hospitals, Ambulatory Surgical Centers
Subsegments:
1) By Endobronchial Ultrasound (EBUS) Needles: Radial EBUS Needles, Linear EBUS Needles, Biopsy EBUS Needles, EBUS Needles With Safety Features, EBUS Needles For Peripheral Lung Lesions
2) By Pulmonary Biopsy Devices: Core Biopsy Needles, Fine Needle Aspiration (FNA) Biopsy Devices, Vacuum-Assisted Biopsy Devices, Transthoracic Biopsy Devices, Endoscopic Pulmonary Biopsy Devices
3) By Airway Stents: Self-Expanding Airway Stents, Balloon-Expandable Airway Stents, Silicone Airway Stents, Metal Airway Stents, Hybrid Airway Stents (Silicone + Metal)
4) By Single-Use Bronchoscopes: Single-Use Flexible Bronchoscopes, Single-Use Rigid Bronchoscopes, Single-Use Pediatric Bronchoscopes, Single-Use Disposable Video Bronchoscopes, Single-Use Bronchoscopes With Integrated Suction
5) By Other Product Types: Pulmonary Function Testing Devices, Nebulizers For Pulmonary Disease Treatment, Spirometers, Pulmonary Inhalation Devices, Non-Invasive Ventilation (NIV) Devices
Pre-Book The Pulmonology Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Pulmonology Devices Market?
Prominent firms in the pulmonology devices market are designing and creating state-of-the-art products by leveraging modern technologies, such as bilevel positive airway pressure (BiPAP) technology. These advancements aim to increase patient's comfort level, elevate the effectiveness of treatments, and tackle a range of respiratory issues. The BiPAP technology utilises dual pressure settings, one each for inhaling (IPAP) and exhaling (EPAP), leading to enhanced comfort for users through continuous pressure. As an example, ResMed, a company based in the US, launched AirCurve 11 bilevel sleep apnea devices in February 2024. These devices, equipped with advanced BiPAP technology, are designed to optimise comfort and adherence for those dealing with sleep apnea and various other respiratory disorders. The advanced AirCurve 11 VAuto model provides varying pressure during exhaling, designed to match the patient's natural breath rhythm. The AirCurve 11 ASV is an adaptive servo-ventilation (ASV) device that monitors 13 different points during each breath cycle 50 times every single second to control and maintain the patient's ventilation levels.
Who Are the Key Players In The Pulmonology Devices Market?
Major companies operating in the pulmonology devices market are:
• Medtronic
• Koninklijke Philips N.V.
• GE Healthcare
• Baxter
• Boston Scientific Corporation
• Medline Industries LP.
• Olympus Corporation
• Omron Healthcare
• ResMed
• Getinge
• ICU Medical Inc.
• Fisher & Paykel Healthcare Limited
• Ambu A/S
• Vyaire Medical Inc.
• Drive DeVilbiss Healthcare
• PENTAX Medical
• Hamilton Medical
• Nonin Medical
• CAIRE Inc.
• Pulmonx Corporation
• Verathon Inc.
• Draegerwerk AG & Co. KGaA
• NIOX
What Is The Most Dominant Region In The Pulmonology Devices Market?
North America was the largest region in the pulmonology devices market in 2024. The regions covered in the pulmonology devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
